Industry calls for EU decision-makers to grasp diverse medtech needs
This article was originally published in Clinica
Executive Summary
The diverse nature of the medtech industry means that it is inappropriate to try and apply the same type of regulations to all devices and create a “one-size-fits-all regulatory” approach. The European Commission’s proposed Medical Device Regulation is a complex technical dossier that addresses an industry with products ranging from low- to high-risk and therefore must not be treated as a single homogenous group.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.